This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in ISI Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via ISI Web of Science (14) Citing Articles via Google Scholar Google Scholar Articles by Loukopoulos, P. Articles by Robinson, W. F. Search for Related Content PubMed PubMed Citation Articles by Loukopoulos, P. Articles by Robinson, W. F.

Matrix Metalloproteinase-2 and -9 Involvement in Canine Tumors

School of Veterinary Science, The University of Queensland, Brisbane, Queensland 4072, Australia

Matrix metalloproteinases (MMPs) are a family of enzymes implicated in the degradation and remodeling of extracellular matrix and in vascularization. They are also involved in pathologic processes such as tumor invasion and metastasis in experimental cancer models and in human malignancies. We used gelatin zymography and immunohistochemistry to determine whether MMP-2 and MMP-9 are present in canine tumors and normal tissues and whether MMP production correlates with clinicopathologic parameters of prognostic importance. High levels of pro–MMP-9, pro–MMP-2, and active MMP-2 were detected in most canine tumors. Significantly higher MMP levels were measured in canine tumors than in nontumors, malignancies had higher MMP levels than benign tumors, and sarcomas had higher active MMP-2 than carcinomas. Cartilaginous tumors produced higher MMP levels than did nonsarcomatous malignancies, benign tumors, and normal tissues, and significantly greater MMP-2 than osteosarcomas and fibrosarcomas. Pro–MMP-9 production correlated with the histologic grade of osteosarcomas. The 62-kd form of active MMP-2 was detected only in high-grade, p53-positive, metastatic malignancies. Zymography proved to be a sensitive and quantitative technique for the assessment of MMP presence but has the limitation of requiring fresh tissue; immunohistochemistry is qualitative and comparatively insensitive but could be of value in archival studies. MMP presence was shown in a range of canine tumors, and their link to tumor type and grade was demonstrated for the first time. This study will allow a substantially improved evaluation of veterinary cancer patients and provides baseline information necessary for the design of clinical trials targeting MMPs.

Key words: Dogs; gelatinases; gelatin zymography; immunohistochemistry; matrix metalloproteinases; neoplasms; p53.

Request reprints from P. Loukopoulos, Pathology Division, National Cancer Center Research Institute, 5-1-1 Tsukiji, Chuo-ku, Tokyo 104-0045 (Japan). E-mail: ploukopo{at}gan2.res.ncc.go.jp.

This article has been cited by other articles:

				P. Loukopoulos, R. H. Sutton, P. Lynch, and D. C. Gee Ectopic mammary carcinoma in a male cat Vet Rec., February 10, 2007; 160(6): 203 - 204. [Full Text] [PDF]

				H. Zeng, M. Briske-Anderson, J. P. Idso, and C. D. Hunt The Selenium Metabolite Methylselenol Inhibits the Migration and Invasion Potential of HT1080 Tumor Cells J. Nutr., June 1, 2006; 136(6): 1528 - 1532. [Abstract] [Full Text] [PDF]

				H. Zeng and M. Briske-Anderson Prolonged Butyrate Treatment Inhibits the Migration and Invasion Potential of HT1080 Tumor Cells J. Nutr., February 1, 2005; 135(2): 291 - 295. [Abstract] [Full Text] [PDF]